Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Abercrombie & Fitch Co. (ANF) an Exceptional Company?

A director at Deloitte Services LP and coauthor of The Three Rules: How Exceptional Companies Think, Michael Raynor joins the Fool to share his findings about what makes a company successful for the long haul.

Abercrombie & Fitch Co. (NYSE:ANF)

In this video segment, taking Abercrombie & Fitch Co. (NYSE:ANF) as an example, Michael describes how the study defines success over the course of a company’s entire history, not just over the last few quarters, even in a volatile industry such as retail. The full version of the interview can be seen here.

A full transcript follows the video.

Video: Michael Raynor Interview (Part 4/8)

Brendan Byrnes: I wanted to ask you specifically about Abercrombie & Fitch Co. (NYSE:ANF), which you say is an exceptional company. I think this might surprise some people, especially when they see the recent comments of the CEO, taking the extra-large and extra-extra-large clothes off the shelf.

Also their earnings. They had fewer earnings last year than they did in, I think, the stretch from 2006 to 2009. Could you maybe go through the process that landed them on the list and the things that you evaluate with them?

Michael Raynor: Yeah. There are a couple of things worth pointing out. First of all, we’re looking at company lifetime, so when I talk about Abercrombie & Fitch Co. (NYSE:ANF), we’re talking about it from 1996 through to today.

The other thing is that the statistical methods that we use are actually pretty immune to the ups and downs of the market. We tend not to get too hung up on what’s been happening not only in the last two or three quarters, but even the last two or three years.

That takes a little getting used to, especially in an industry like retail, where if I said to you, “You really have to understand the last 10 years in order to understand your performance,” some people would look at me … they’d kind of squint a bit. But we feel we have good reason for looking at it that way.

I guess the last thing to point out is that when it comes to the specific choices that get made, well, that’s kind of why we play the game. The rules, we think are very helpful, but they’re not a road map. They don’t prescribe precisely what you need to do to be successful. They indicate which hard problem you should try and solve.

When we look at the Miracle Workers that stay there, they stay focused on those hard problems even if they have speed bumps or hiccups along the way.

Brendan: How do you think we extrapolate this forward? Obviously the data is backward-looking…

Michael: All data are.

Brendan: Right, so how do we ensure that the data… maybe a company was great in the past. How do we ensure that they stay great in the future?

Michael: Well, the hope is that’s where the rules come in handy. They’re a compass. They point. They say, “The great performance lies that way.”

Companies that remain focused on moving in that direction, those are the companies that we feel will have the best chance of continuing or creating a run of exceptional performance.

The article Is Abercrombie an Exceptional Company? originally appeared on and is written by Brendan Byrnes.

Brendan Byrnes has no position in any stocks mentioned, and neither does The Motley Fool.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!